Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey.
Patient-centered clinical trial design and execution is becoming increasingly important. No best practice guidelines exist despite a key stakeholder declaration to create more effective engagement models. This study aims to gain a better understanding of attitudes and practices for engaging patient...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4605726?pdf=render |
| _version_ | 1818164201211822080 |
|---|---|
| author | Sophia K Smith Wendy Selig Matthew Harker Jamie N Roberts Sharon Hesterlee David Leventhal Richard Klein Bray Patrick-Lake Amy P Abernethy |
| author_facet | Sophia K Smith Wendy Selig Matthew Harker Jamie N Roberts Sharon Hesterlee David Leventhal Richard Klein Bray Patrick-Lake Amy P Abernethy |
| author_sort | Sophia K Smith |
| collection | DOAJ |
| description | Patient-centered clinical trial design and execution is becoming increasingly important. No best practice guidelines exist despite a key stakeholder declaration to create more effective engagement models. This study aims to gain a better understanding of attitudes and practices for engaging patient groups so that actionable recommendations may be developed.Individuals from industry, academic institutions, and patient groups were identified through Clinical Trials Transformation Initiative and Drug Information Association rosters and mailing lists. Objectives, practices, and perceived barriers related to engaging patient groups in the planning, conduct, and interpretation of clinical trials were reported in an online survey. Descriptive and inferential statistical analysis of survey data followed a literature review to inform survey questions.Survey respondents (n = 179) valued the importance of involving patient groups in research; however, patient group respondents valued their contributions to research protocol development, funding acquisition, and interpretation of study results more highly than those contributions were valued by industry and academic respondents (all p < .001). Patient group respondents placed higher value in open communications, clear expectations, and detailed contract execution than did non-patient group respondents (all p < .05). Industry and academic respondents more often cited internal bureaucratic processes and reluctance to share information as engagement barriers than did patient group respondents (all p < .01). Patient groups reported that a lack of transparency and understanding of the benefits of collaboration on the part of industry and academia were greater barriers than did non-patient group respondents (all p< .01).Despite reported similarities among approaches to engagement by the three stakeholder groups, key differences exist in perceived barriers and benefits to partnering with patient groups among the sectors studied. This recognition could inform the development of best practices for patient-centered clinical trial design and execution. Additional research is needed to define and optimize key success factors. |
| first_indexed | 2024-12-11T17:01:41Z |
| format | Article |
| id | doaj.art-2aeefb7244f948eeac5a9f10ecf2998b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T17:01:41Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2aeefb7244f948eeac5a9f10ecf2998b2022-12-22T00:57:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014023210.1371/journal.pone.0140232Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey.Sophia K SmithWendy SeligMatthew HarkerJamie N RobertsSharon HesterleeDavid LeventhalRichard KleinBray Patrick-LakeAmy P AbernethyPatient-centered clinical trial design and execution is becoming increasingly important. No best practice guidelines exist despite a key stakeholder declaration to create more effective engagement models. This study aims to gain a better understanding of attitudes and practices for engaging patient groups so that actionable recommendations may be developed.Individuals from industry, academic institutions, and patient groups were identified through Clinical Trials Transformation Initiative and Drug Information Association rosters and mailing lists. Objectives, practices, and perceived barriers related to engaging patient groups in the planning, conduct, and interpretation of clinical trials were reported in an online survey. Descriptive and inferential statistical analysis of survey data followed a literature review to inform survey questions.Survey respondents (n = 179) valued the importance of involving patient groups in research; however, patient group respondents valued their contributions to research protocol development, funding acquisition, and interpretation of study results more highly than those contributions were valued by industry and academic respondents (all p < .001). Patient group respondents placed higher value in open communications, clear expectations, and detailed contract execution than did non-patient group respondents (all p < .05). Industry and academic respondents more often cited internal bureaucratic processes and reluctance to share information as engagement barriers than did patient group respondents (all p < .01). Patient groups reported that a lack of transparency and understanding of the benefits of collaboration on the part of industry and academia were greater barriers than did non-patient group respondents (all p< .01).Despite reported similarities among approaches to engagement by the three stakeholder groups, key differences exist in perceived barriers and benefits to partnering with patient groups among the sectors studied. This recognition could inform the development of best practices for patient-centered clinical trial design and execution. Additional research is needed to define and optimize key success factors.http://europepmc.org/articles/PMC4605726?pdf=render |
| spellingShingle | Sophia K Smith Wendy Selig Matthew Harker Jamie N Roberts Sharon Hesterlee David Leventhal Richard Klein Bray Patrick-Lake Amy P Abernethy Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. PLoS ONE |
| title | Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. |
| title_full | Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. |
| title_fullStr | Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. |
| title_full_unstemmed | Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. |
| title_short | Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. |
| title_sort | patient engagement practices in clinical research among patient groups industry and academia in the united states a survey |
| url | http://europepmc.org/articles/PMC4605726?pdf=render |
| work_keys_str_mv | AT sophiaksmith patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT wendyselig patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT matthewharker patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT jamienroberts patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT sharonhesterlee patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT davidleventhal patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT richardklein patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT braypatricklake patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey AT amypabernethy patientengagementpracticesinclinicalresearchamongpatientgroupsindustryandacademiaintheunitedstatesasurvey |